die('
Site is under construction
Dear site users
Site is under construction.
The site will be ready in less than 24 hours.
We are sorry for the inconvenience.
www.yektaweb.com
');
Reports of Biochemistry and Molecular Biology
rbmb.net
Basic Sciences
http://rbmb.net
1
admin
2322-3480
2322-3480
10.61882/rbmb
en
jalali
1400
10
1
gregorian
2022
1
1
10
4
online
1
fulltext
en
Clinical Significance of Circulating Serum Levels of sCD95 and TNF-α in Cytoprotection of Cervical Cancer
بیوشیمی
Biochemistry
مقالات اصلی
Original Article
<div style="text-align: justify;"><em><strong>Background:</strong></em> This study correlates the serum levels of sCD95 & TNF-α with a simple cell-based assay to evaluate the capacity of the serum sample to induce apoptosis in Jurkat cells. Interlinking of these parameters can be explored to design a minimum invasive diagnostic strategy for cervical cancer (CC).<br>
<br>
<em><strong>Methods: </strong></em>Sera samples were assessed to induce apoptosis in Jurkat cells through FACS. Serum levels of sCD95 and TNF-α were measured by ELISA. JNK phosphorylation was evaluated in sera incubated Jurkat cells. Data was scrutinized through statistical analysis.<br>
<br>
<em><strong>Results:</strong></em> Significantly higher serum levels of sCD95 and lower TNF-α levels were observed in CC patients; their sera samples inhibited induction of apoptosis in Jurkat cells through reduced JNK phosphorylation. Statistical analysis linked these three parameters for the early screening of CC.<br>
<br>
<em><strong>Conclusions:</strong></em> Distinct sera levels of sCD95 & TNF-α in CC patients showed an anti-apoptotic effect, which can be considered for early detection of CC.</div>
Apoptosis, sCD95, Jurkat Cells, Tumor Necrosis Factor-alpha, Uterine Cervical Neoplasms.
711
721
http://rbmb.net/browse.php?a_code=A-10-723-1&slc_lang=en&sid=1
Saurabh Kumar
Agnihotri
100319475328460012493
100319475328460012493
No
Department of Radiotherapy, King George’s Medical University, Lucknow 226 003, India & Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow 226 031, India.
Balawant
Kumar
100319475328460012494
100319475328460012494
No
Division of Toxicology & Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow 226 031, India.
Ankita
Jain
100319475328460012495
100319475328460012495
No
Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow 226 031, India.
Anjali
Anjali
100319475328460012496
100319475328460012496
No
Division of Toxicology & Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow 226 031, India & Department of Obstetrics & Gynaecology, King George’s Medical University, Lucknow 226 003, India.
Mahendra Pal Singh
Negi
100319475328460012497
100319475328460012497
No
Division of Toxicology & Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow 226 031, India.
Rekha
Sachan
100319475328460012498
100319475328460012498
No
Department of Obstetrics & Gynaecology, King George’s Medical University, Lucknow 226 003, India.
Madan Lal Brahma
Bhatt
100319475328460012499
100319475328460012499
No
Department of Radiotherapy, King George’s Medical University, Lucknow 226 003, India.
Rekha
Sachan
100319475328460012500
100319475328460012500
No
Department of Obstetrics & Gynaecology, King George’s Medical University, Lucknow 226 003, India.
Madan Lal Brahma
Bhatt
100319475328460012501
100319475328460012501
No
Department of Radiotherapy, King George’s Medical University, Lucknow 226 003, India.
Raj Kamal
Tripathi
100319475328460012502
100319475328460012502
No
Division of Toxicology & Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow 226 031, India & Department of Obstetrics & Gynaecology, King George’s Medical University, Lucknow 226 003, India.
Monika
Sachdev
monika@cdri.res.in.
100319475328460012503
100319475328460012503
Yes
Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow 226 031, India & Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201 002, India.